Research / CALY / Fundamental state Inspectable configuration
State dimensions Filing 0000837465-22-000016 General Corporate
Debt relative to revenue 50th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.debt_to_revenue
97.08% · OPTIONAL · VALID
Capex intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
10.64% · OPTIONAL · VALID
Operating cash generation 55th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.30% · OPTIONAL · VALID
Revenue growth 44th Own-history percentile · N=16
Evidence method Yoy · gp.fundamentals.revenue
22.12% · CORE · VALID
Inventory pressure 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
54.14% · OPTIONAL · VALID
Operating margin 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
11.56% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.68% · OPTIONAL · VALID
SBC intensity 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.18% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 104.42%
Current 97.08%
Delta -7.34% Capex Intensity Decreased
Previous 11.95%
Current 10.64%
Delta -1.31% Cash Generation Increased
Previous -17.81%
Current 12.30%
Delta 30.11% Growth Decreased
Previous 59.63%
Current 22.12%
Delta -37.52% Inventory Pressure Increased
Previous 53.11%
Current 54.14%
Delta 1.03% Profitability Increased
Previous 9.07%
Current 11.56%
Delta 2.50% R And D Intensity Decreased
Previous 1.68%
Current 1.68%
Delta -0.01% Sbc Intensity Decreased
Previous 1.33%
Current 1.18%
Delta -0.14% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.